-+ 0.00%
-+ 0.00%
-+ 0.00%

EXICURE, INC. (NASDAQ: XCUR) ANNOUNCES THEIR NEXT STEP IN PLANNING FOR A NEW CLINICAL TRIAL IN ACUTE MYELOID LEUKEMIA (AML)

Reuters·04/11/2025 23:42:00

Please log in to view news